Ciappenelli Robert D. 4
4 · Dicerna Pharmaceuticals Inc · Filed Dec 14, 2021
Insider Transaction Report
Form 4
Ciappenelli Robert D.
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-13$22.58/sh+8,856$199,968→ 12,629 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-12-13−8,856→ 76,144 totalExercise: $22.58Exp: 2030-01-07→ Common Stock (8,856 underlying)
Footnotes (1)
- [F1]The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2020, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the reporting person's continued service with the issuer through each applicable vesting date.